Evidence map›Paper›PMID 33655402›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2021

Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.

J C Horng, E Van Eperen, S Tutton, R Singh, J L Shaker, A N Wooldridge

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Significant limitations and a future roadmap for the Li nomogram in tumor-induced osteomalacia.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Phosphaturic Mesenchymal Tumor.AJNR. American journal of neuroradiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J C HorngDepartment of Orthopaedic Surgery, Medical College of Wisconsin, Wauwatosa, WI, 53213, USA.
E Van EperenDepartment of Orthopaedic Surgery, Medical College of Wisconsin, Wauwatosa, WI, 53213, USA.
S TuttonDepartment of Vascular and Interventional Radiology, Medical College of Wisconsin, Wauwatosa, WI, 53213, USA.
R SinghDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
J L ShakerDepartment of Medicine (Endocrinology), Medical College of Wisconsin, Milwaukee, WI, USA.
A N WooldridgeDepartment of Orthopaedic Surgery, Medical College of Wisconsin, Wauwatosa, WI, 53213, USA. awooldridge@mcw.edu.
Medical College of Wisconsin · US

Funding

Medical College of Wisconsin: Department of Orthopaedic Surgery N/A
6 · The paper itself

Abstract

Phosphaturic mesenchymal tumors (PMTs) can present with vague symptoms of diffuse bone pain with pathologic fractures that often lead to a delayed diagnosis. We present a 60-year-old patient with a PMT that was persistently hypophosphatemic after resection, who was then successfully treated with cryoablation of the tumor. Tumor-induced osteomalacia (TIO) is a rare cause of hypophosphatemia characterized by vague symptoms of gradual muscle weakness and diffuse bone pain with pathologic fractures that often lead to a delayed diagnosis. This condition is usually caused by benign phosphaturic mesenchymal tumors (PMTs). Here, we present a case of persistent PMT after surgical resection treated with image-guided ablation. We present the patient's clinical examinations and laboratory findings (phosphorus, 1,25 (OH)

Indexed as

HypophosphatemiaNeoplasms, Connective TissueOsteomalaciaSoft Tissue NeoplasmsFibroblast Growth Factor-23HumansMaleMiddle AgedParaneoplastic SyndromesFibroblast Growth Factor-23FGF-23HypophosphatemiaImage-guided ablationPhosphaturic mesenchymal tumorTumor-induced osteomalacia

Identifiers

PMID33655402
OpenAlexW3135649709

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.